Takayusu Arteritis on the background of congenital vascular anomaly?
https://doi.org/10.18087/cardio.2020.6.n688
Abstract
The article described a female patient with high-grade arterial hypertension diagnosed at her young age. Congenital abdominal aortic hyperplasia and conformity with criteria for Takayasu arteritis were diagnosed at 10 years following the clinical manifestation.
Keywords
Essential arterial hypertension,
secondary arterial hypertension,
Takayasu arteritis,
abnormality of the vasculature
Supporting agencies: The authors declare that they have no conflict of interest.
About the Authors
I. E. Borodina
Urals State Medical University, Yekaterinburg, Russia
Urals State Regional clinical hospital # 1, Yekaterinburg, Russia
Russian Federation
Russian Federation
general physician Urals State Hospital # 1, post- graduate student of Urals State Medical University
I. V. Sablin
Urals State Regional clinical hospital # 1, Yekaterinburg, Russia
Russian Federation
Russian Federation
radiologist Urals State Hospital # 1,
A. A. Popov
Urals State Medical University, Yekaterinburg, Russia
Russian Federation
Russian Federation
m.d.,ph.d. Hospital Therapy and Emergency Medicine Department
the Urals State Medical University
A. N. Ageev
Urals State Medical University, Yekaterinburg, Russia
Urals State Regional clinical hospital # 1, Yekaterinburg, Russia
Russian Federation
Russian Federation
radiologist Urals State Hospital # 1, Urals State Medical University,
References
1. Nasonov E.L., Nasonova V.A. Rheumatology. National Manual. -M.: GEOTAR-Media;2010. - 720 p. ISBN 978-5-9704-1650-1
2. Alibaz-Oner F, Aydin SZ, Direskeneli H. Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis. Clinical Rheumatology. 2013;32(5):541–6. DOI: 10.1007/s10067-012-2149-3
3. Lalhmachhuani PC, Daimei SL, Ralte RL, Manpang NN, Jaleel MP. A Case Of Takayasu Arteritis In Elderly Male Patient. Indian Journal of Medical Research and Pharmaceutical Sciences. 2017;4(12):34–8. DOI: 10.5281/ZENODO.1117652
4. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018;39(33):3021–104. DOI: 10.1093/eurheartj/ehy339
5. Podzolkov V.I., Perepech N.B., Oshepkova E.V., Ostroumova O.D., Oganov R.G., Nikitin Yu.P. et al. Diagnosis and treatment of arterial hypertension. Russian recommendations (third revision). Cardiovascular Therapy and Prevention. 2008;7(6 S2):1–32.
6. De Souza AWS, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. Journal of Autoimmunity. 2014;48–49:79–83. DOI: 10.1016/j.jaut.2014.01.012
7. Restrepo CS, Ocazionez D, Suri R, Vargas D. Aortitis: Imaging Spectrum of the Infectious and Inflammatory Conditions of the Aorta. RadioGraphics. 2011;31(2):435–51. DOI: 10.1148/rg.312105069
8. Cimmino MA, Camellino D. Large vessel vasculitis: which imaging method? Swiss Medical Weekly. 2017;147:w14405. DOI: 10.4414/smw.2017.14405
9. Akter F, Ward K. Large-vessel GCA or a late presentation of Takayasu’s arteritis? Case Reports. 2012;2012:bcr0320125995. DOI: 10.1136/bcr.03.2012.5995
10. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adultThe Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). European Heart Journal. 2014;35(41):2873–926. DOI: 10.1093/eurheartj/ehu281
11. Hatri A, Guermaz R, Laroche J-P, Zekri S, Brouri M. Artérite de Takayasu et athérosclérose. JMV-Journal de Médecine Vasculaire. 2019;44(5):311–7. DOI: 10.1016/j.jdmv.2019.07.002
12. Uzunlar B, Karabulut A, Dogan Z, Cakmak M. Coronary-carotid artery collateral formation in Takayasu’s arteritis: First reported case in the literature. Journal of Cardiology Cases. 2014;9(4):151–3. DOI: 10.1016/j.jccase.2013.12.010
13. Balink H, Verberne HJ, Bennink RJ, van Eck-Smit BLF. A Rationale for the Use of F18-FDG PET/CT in Fever and Inflammation of Unknown Origin. International Journal of Molecular Imaging. 2012;2012:1–12. DOI: 10.1155/2012/165080
14. Tarkin JM, Rudd JHF. Techniques for noninvasive molecular imaging of atherosclerotic plaque. Nature Reviews Cardiology. 2015;12(2):79. DOI: 10.1038/nrcardio.2014.80-c2
15. Shalyga I.F., Kozlovskaya T.V., Martemyanova L.A. Takayasu’s disease. Problems of Health and Ecology. 2014;4(42):135–9.
16. Kim ESH, Beckman J. Takayasu arteritis: challenges in diagnosis and management. Heart. 2018;104(7):558–65. DOI: 10.1136/heartjnl-2016-310848
17. Vaideeswar P, Deshpande J. Pathology of Takayasu arteritis: A brief review. Annals of Pediatric Cardiology. 2013;6(1):52–8. DOI: 10.4103/0974-2069.107235
18. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). International Journal of Cardiology. 1998;66(Suppl 1):S191-194; discussion S195. DOI: 10.1016/s0167-5273(98)00181-8
19. Mikolajczyk TP, Nosalski R, Szczepaniak P, Budzyn K, Osmenda G, Skiba D et al. Role of chemokine RANTES in the regulation of perivascular inflammation, T‐cell accumulation, and vascular dysfunction in hypertension. The FASEB Journal. 2016;30(5):1987–99. DOI: 10.1096/fj.201500088R
20. Sun Y, Kong X, Cui X, Dai X, Ma L, Chen H et al. The value of interleukin-6 in predicting disease relapse for Takayasu arteritis during 2-year follow-up. Clinical Rheumatology. 2020; [Epub ahead of print]. DOI: 10.1007/s10067-020-05066-8
21. Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A et al. Matrix Metalloproteinases as Novel Disease Markers in Takayasu Arteritis. Circulation. 2003;108(12):1469–73. DOI: 10.1161/01.CIR.0000090689.69973.B1
22. Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Annals of the Rheumatic Diseases. 2018;77(5):636–43. DOI: 10.1136/annrheumdis-2017-212649
23. Schmidt J, Kermani TA, Bacani AK, Crowson CS, Cooper LT, Matteson EL et al. Diagnostic Features, Treatment, and Outcomes of Takayasu Arteritis in a US Cohort of 126 Patients. Mayo Clinic Proceedings. 2013;88(8):822–30. DOI: 10.1016/j.mayocp.2013.04.025
24. Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Annals of the Rheumatic Diseases. 2020;79(1):19–30. DOI: 10.1136/annrheumdis-2019-215672
25. Barra L, Yang G, Pagnoux C. Non-glucocorticoid drugs for the treatment of Takayasu’s arteritis: A systematic review and meta-analysis. Autoimmunity Reviews. 2018;17(7):683–93. DOI: 10.1016/j.autrev.2018.01.019
26. Russo RAG, Katsicas MM. Takayasu Arteritis. Frontiers in Pediatrics. 2018;6:265. DOI: 10.3389/fped.2018.00265
27. Comarmond C, Plaisier E, Dahan K, Mirault T, Emmerich J, Amoura Z et al. Anti TNF-α in refractory Takayasu’s arteritis: Cases series and review of the literature. Autoimmunity Reviews. 2012;11(9):678–84. DOI: 10.1016/j.autrev.2011.11.025
28. Beketova T.V., Nasonov E.L. Innovative treatments for Takayasu’s arteritis: A focus on interleukin-6 inhibitors. The authors’ experience with tocilizumab and a review of literature. Rheumatology Science and Practice. 2017;55(5):536–48. DOI: 10.14412/1995-4484-2017-536-548
29. Unizony S, Stone JH, Stone JR. New treatment strategies in large-vessel vasculitis: Current Opinion in Rheumatology. 2013;25(1):3–9. DOI: 10.1097/BOR.0b013e32835b133a
30. Novikov P.I., Smitienko I.O., Sokolova M.V., Moiseev S.V. Certolizumab pegol in the treatment of Takayasu arteritis: the first experience and prospects. Rheumatology Science and Practice. 2018;56(3):333–8. DOI: 10.14412/1995-4484-2018-333-338
31. Bokeria L.A., Pokrovskiy A.V., Sokurenko G.Yu., Samorodskaya I.V., Abugov S.A., Alekyan B.G. et al. National guidelines for the management of patients with diseases of the brachiocephalic arteries. Russian conciliation document. Angiology and Vascular Surgery. 2013;19(2 Suppl):1–72.
32. Pokrovskiy A.V., Zotikov A.E., Kul’bak V.A., Burtseva E.A. Problems of diagnostics and treatment strategy in patients with Takayasu’ arteries. Annals of the Russian Academy of Medical Sciences. 2010;10:9–19.
Review
For citations:
Borodina I.E., Sablin I.V., Popov A.A., Ageev A.N. Takayusu Arteritis on the background of congenital vascular anomaly? Kardiologiia. 2020;60(6):13–118. (In Russ.) https://doi.org/10.18087/cardio.2020.6.n688
Views:
1088
Email this article 
Post a Comment 
